Steketee J D, Goeders N E
Departments of Pharmacology and Therapeutics, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA.
Behav Pharmacol. 2002 Nov;13(7):593-601. doi: 10.1097/00008877-200211000-00008.
It has been suggested that stress, via corticosterone secretion, can modulate some of the behavioural responses to cocaine. In particular, we have demonstrated that daily exposure to electric footshock stress or daily pretreatment with corticosterone shifts the ascending limb of the dose-response curve for the acquisition of cocaine self-administration upwards and to the left. It has been suggested that this corticosterone-induced increase in sensitivity to low doses of cocaine is associated with an enhancement of dopaminergic neurotransmission. The present study was designed to test this hypothesis. Adult male rats were pretreated with corticosterone (2.0 mg/kg intraperitoneally) 15 min prior to an injection of cocaine (5.0, 10.0 or 20.0 mg/kg intraperitoneally), and motor activity and extracellular dopamine concentrations in the nucleus accumbens were monitored. Cocaine administration resulted in dose-related increases in motor activity that were unaffected by pretreatment with corticosterone. However, rather than augmenting cocaine-induced increases in dopamine in the nucleus accumbens, corticosterone pretreatment actually caused attenuation at the two highest doses of cocaine tested. These data suggest dissociation between locomotor activation and nucleus accumbens dopamine responses to cocaine, and indicate that other brain regions and/or mechanisms may be involved in the changes in sensitivity to cocaine induced by corticosterone.
有人提出,压力通过皮质酮分泌,可以调节对可卡因的一些行为反应。特别是,我们已经证明,每天暴露于电休克应激或每天用皮质酮预处理会使可卡因自我给药获取的剂量反应曲线的上升支向上和向左移动。有人认为,这种皮质酮诱导的对低剂量可卡因敏感性增加与多巴胺能神经传递的增强有关。本研究旨在验证这一假设。成年雄性大鼠在注射可卡因(腹腔注射5.0、10.0或20.0mg/kg)前15分钟用皮质酮(腹腔注射2.0mg/kg)预处理,并监测其运动活动和伏隔核细胞外多巴胺浓度。可卡因给药导致运动活动剂量相关增加,这不受皮质酮预处理的影响。然而,皮质酮预处理非但没有增强可卡因诱导的伏隔核多巴胺增加,实际上在测试的两个最高可卡因剂量下导致了衰减。这些数据表明运动激活与伏隔核对可卡因的多巴胺反应之间存在分离,并表明其他脑区和/或机制可能参与了皮质酮诱导的对可卡因敏感性变化。